28.54
-0.2217(-0.77%)
Currency In USD
| Previous Close | 28.76 |
| Open | 28.75 |
| Day High | 28.82 |
| Day Low | 28.42 |
| 52-Week High | 62.53 |
| 52-Week Low | 24.1 |
| Volume | 56,602 |
| Average Volume | 864,740 |
| Market Cap | 2.67B |
| PE | -7.51 |
| EPS | -3.8 |
| Moving Average 50 Days | 31.45 |
| Moving Average 200 Days | 42.31 |
| Change | -0.22 |
If you invested $1000 in Crinetics Pharmaceuticals, Inc. (CRNX) since IPO date, it would be worth $1,164.35 as of July 01, 2025 at a share price of $28.538. Whereas If you bought $1000 worth of Crinetics Pharmaceuticals, Inc. (CRNX) shares 5 years ago, it would be worth $1,615.99 as of July 01, 2025 at a share price of $28.538.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
GlobeNewswire Inc.
Yesterday at 8:05 PM GMT
Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both biochemical and symptom control with a well-tolerated safety profile in patients switching treatments and those not previously p
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
GlobeNewswire Inc.
Jun 16, 2025 12:00 PM GMT
SAN DIEGO, June 16, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host an in-person and virtual R&D Day in New York on Thursday, June 26, 2025, from 9:00 AM to 12:00 PM ET. The event will prov
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jun 10, 2025 8:29 PM GMT
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggrega